Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32
|
0.700 |
Biomarker |
GENOMICS_ENGLAND |
A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia.
|
27543892 |
2016 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32
|
0.700 |
Biomarker |
GENOMICS_ENGLAND |
A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia.
|
27543892 |
2016 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32
|
0.700 |
GeneticVariation |
UNIPROT |
Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy.
|
25477152 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32
|
0.700 |
GeneticVariation |
UNIPROT |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32
|
0.700 |
Biomarker |
CTD_human |
|
|
|
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Epileptic encephalopathy
|
0.460 |
Biomarker |
GENOMICS_ENGLAND |
|
|
|
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Seizures
|
0.430 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Intellectual Disability
|
0.400 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Tonic - clonic seizures
|
0.310 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Convulsions
|
0.310 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Profound Mental Retardation
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Jacksonian Seizure
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Language Delay
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Language Development Disorders
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Mental Retardation, Psychosocial
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Complex partial seizures
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Generalized seizures
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Clonic Seizures
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Speech Delay
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Visual seizure
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Tonic Seizures
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Epileptic drop attack
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Seizures, Somatosensory
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Seizures, Auditory
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |
Entrez Id: |
3737 |
Gene Symbol: |
KCNA2 |
KCNA2
|
Olfactory seizure
|
0.300 |
Biomarker |
CTD_human |
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
|
25751627 |
2015 |